Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective

• Main Authors: Mehdi Bakhtiyaridovvombaygi (Author), Somayeh Yazdanparast (Author), Setare Kheyrandish (Author), Seyed Mehrab Safdari (Author), Fateme Amiri Samani (Author), Mahsa Sohani (Author), Akram Sadat Jaafarian (Author), Fateme Damirchiloo (Author), Amirhossein Izadpanah (Author), Sahar Parkhideh (Author), Fatemeh Mikanik (Author), Elham Roshandel (Author), Abbas Hajifathali (Author), Ahmad Gharehbaghian (Author)
• Format: Book
• Published: BMC, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Non-Hodgkin lymphomas (NHLs) are heterogeneous and are among the most common hematological malignancies worldwide. Despite the advances in the treatment of patients with NHLs, relapse or resistance to treatment is anticipated in several patients. Therefore, novel therapeutic approaches are...